Clinical Trial Update: An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden

View source ↗

Summary

An observational trial update from Bayer describes exposure to interferon-beta during the second and third trimesters in pregnant women in Finland and Sweden. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaseron (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis (MS) | Status: ACTIVE_NOT_RECRUITING